HRT Financial’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TVTX
HRT Financial's TVTX Position: Q3 2026 in Review
HRT Financial sold out of Travere Therapeutics (TVTX) in Q3 2026, closing a stake of 56,624 shares — an estimated $3.46M sold.
HRT Financial first reported a position in TVTX in Q4 2019 and held it in 12 quarters. The position peaked at $5.16M in Q1 2026. 345 funds tracked by Wall St. Rank hold TVTX as of Q3 2026.
- HRT Financial reported no remaining Travere Therapeutics position as of Q3 2026 after selling out during the quarter.
- HRT Financial sold 56,624 Travere Therapeutics shares in Q3 2026, an estimated $3.46M.
- HRT Financial first reported a position in Travere Therapeutics in Q4 2019 and held it in 12 quarters.
- HRT Financial's Travere Therapeutics position peaked at $5.16M in Q1 2026.
- 345 funds tracked by Wall St. Rank held Travere Therapeutics as of Q3 2026.
Based on HRT Financial's 13F filing for Q3 2026, filed 13 Nov 2026.